Compare Cassava Sciences Inc (FLNA) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Vanguard Intermediate Term Corporate Bond ETF trades at $81.18. Which is the better fit depends on your goals.
| FLNA | VCIT | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | Fixed Income |
52-Week High | $4.64 | $84.82 |
52-Week Low | $0.87 | $81.07 |
Enterprise Value | -$34.93M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Vanguard Intermediate Term Corporate Bond ETF
VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.
Read more on VCIT →
